SCHEMBL23939088

SCHEMBL23939088

O=C1c2cccc(NC(O)(O)c3ccc(C(O)(O)N4CCOCC4)cc3F)c2C(O)(O)N1C1(O)C(=O)NC(=O)C(O)(O)C1(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23938929 0.94 — —
SCHEMBL21924031 0.93 — —
SCHEMBL21281534 0.93 — —
SCHEMBL21281493 0.85 — —
SCHEMBL21281531 0.84 — —
SCHEMBL23939108 0.84 — —
SCHEMBL21925263 0.82 — —
SCHEMBL21281566 0.82 — —
SCHEMBL21924042 0.81 — —
SCHEMBL21281330 0.78 CRBN (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-B1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF KANGPU BIOPHARMACEUTICALS LTD (CN) 2021-10-20 — — EP disclosed
Send feedback